![]() | Adrienne Dorf |
KOL Resume for Adrienne Dorf
Year |
---|
Adrienne Dorf: Influence Statistics
Concept | World rank |
---|---|
pancreatic enzyme products | #24 |
extracts pancrelipase | #66 |
Open the FULL List in Excel | |
Prominent publications by Adrienne Dorf
Treatment Failure After Substitution of Generic Pancrelipase Capsules: Correlation With In Vitro Lipase Activity
[ PUBLICATION ]
Pancreatic enzyme products are formulated, manufactured, and sold without submitting efficacy or bioavailability data to the Food and Drug Administration because of a quirk in the law. We documented therapeutic failures in three patients with cystic fibrosis after pharmacists substituted generic pancrelipase capsules for the Pancrease brand. Gastrointestinal symptoms and fat malabsorption rapidly resolved after therapy was reinstituted with brand name products. In vitro analysis ...
Known for Treatment Failure | Food Drug Administration | Lipase Activity | Cystic Fibrosis | Enteric Coating |
Key People For Patients Cystic Fibrosis
Adrienne Dorf:Expert Impact
Concepts for whichAdrienne Dorfhas direct influence:Patients cystic fibrosis, Lipase activity, Enteric coating, Pancreatic enzyme products, Fat malabsorption, Therapeutic equivalency, Generic product, Products vitro.
Adrienne Dorf:KOL impact
Concepts related to the work of other authors for whichfor which Adrienne Dorf has influence:Cystic fibrosis, Generic substitution, Chronic pancreatitis, Pancreatic enzyme, Postoperative infections, Antimicrobial prophylaxis, Individual bioequivalence.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |